Prostate Cancer Diagnostics Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 18
SKU : PH2247
180 pages
Report Summary
Table of Contents
List of Tables & Figures
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
Request new version
FAQ’s
How big is the Prostate Cancer Diagnostics Market ?
Global Prostate Cancer Diagnostics Market reached US$ 5.1 billion in 2022 and is expected to reach US$ 11.6 billion by 2031
Who are the key players in Prostate Cancer Diagnostics Market ?
Key players are Myriad Genetics, Inc., Quanterix Corporation, MDx Health, Siemens Healthineers, F. Hoffman-La Roche AG, OPKO Health, Inc., Thermo Fisher Scientific Inc., Cellanyx Diagnostics Inc., MiR Scientific and Proteomedix.
Related Reports
pharmaceuticalsUS Prostate Cancer Instruments and Test Market Size, Share, Industry, Forecast and Outlook (2023-2030)
Published: 2023 October 06
Starting from
$3175
pharmaceuticalsNoninvasive Cancer Diagnostics Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 24
Starting from
$4350
pharmaceuticalsDiabetic Retinopathy Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 05
Starting from
$4350
pharmaceuticalsDiabetic Macular Edema Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 05
Starting from
$4350
pharmaceuticalsType 2 Diabetes Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 05
Starting from
$4350
pharmaceuticalsPharmaceutical Suppositories Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 August 23
Starting from
$4350